norm: alzamend neuroNAICS Pharmaceutical Preparations · USno LEI · CIK 0001677077Max severity: Low

Canonical registry

Alzamend Neuro, Inc.

ent_019fa1e5e89e3e57d6da38a37ad7c217

Compliance scorecard →🔔 Follow entity

Disclosures

1

SEC 10-K Item 1C · 1 jurisdiction

Incidents

—

no linked incident in sample

Max affected reported

—

no filed count in sample

Leak-site claims

0

none in sample

Identity resolution

Canonical name: Alzamend Neuro, Inc.
Normalized: alzamend neuro— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: 0001677077
Domain: None on record

Disclosure history (1)newest first

FEDERALSEC 10-K Item 1Cas victim2024-07-30
Item 1C of a 10-K filing describing the registrant's cybersecurity risk management program, governance, and policies. The filing states that during fiscal 2024, no cybersecurity threats were identified that have materially affected or are reasonably likely to materially affect business strategy, results of operations, or financial condition. No actual cybersecurity incident is disclosed.